Mr. Tom Tamberrino is a seasoned leader with a distinguished career in sales and marketing leadership, business development, and executive management, with much of his success rooted in the U.S. healthcare industry. He brings a wealth of experience, including a history of entrepreneurial ventures and significant contributions to the medical technology sector. Prior to joining Profound Medical, Mr. Tamberrino served as Vice President of Sales and Marketing at Novadaq Technologies Inc. for several years. Under his leadership, Novadaq established itself as the market leader in near-infrared fluorescence imaging, achieving remarkable growth and driving revenues from an annual run rate of $27 million in 2012 to over $82 million in 2017. This growth culminated in Novadaq’s acquisition by Stryker Corporation for approximately $701 million, after which Mr. Tamberrino continued with Stryker until 2018 to support the integration of Novadaq’s business. Earlier in his career, Mr. Tamberrino held progressive sales management positions at LifeCell Corporation, eventually serving as Area Director. During his time at LifeCell Corporation, he led a 50-person sales team across the Northeastern U.S. and Canada, marketing regenerative tissue matrices. Mr. Tamberrino holds a Bachelor of Science degree in Marketing with a Minor in Psychology from Georgetown University and a Master of Business Administration from Emory University.

• 

  Chief Commercial Officer in Profound Medical

  Incision-Free Ablative Intervention, with Vision